Marc Thibonnier

Marc Thibonnier

Company: AptamiR Therapeutics

Job title: Founder & President


One Drug Multiple Targets: Simultaneously Modulating Several Target Genes in Obesity, Diabetes & MAFLD 1:00 pm

Developing targeting microRNA oligonucleotide therapeutics for cardiometabolic disorders Mice, rats, monkeys, and in silico: demonstrating proof of efficacy in vitro in primary cultures of human cells and animal models Modulating multiple target genes with miRNA ONTs to treat multi-factorial diseasesRead more

day: Day 2 Stream 1 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.